Value through Innovation27 July 2016

Clinical Study Results

  • BI 847325 - Neoplasms
    Clinical Study Number 1287.1
    Study Indication Neoplasms
    Product BI 847325
    Generic Name BI 847325
    Lab Code
    Clinical Phase Ia/Ib
    Study Title

    An open-label, uncontrolled Phase Ia/Ib study of two dosing schedules of BI 847325 orally administered once a day in patients with advanced solid tumours, with repeated administration in patients with clinical benefit

    Study Document Trial synopsis 1287.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.